Archit Organosys マネジメント

マネジメント基準チェック /24

現在、CEO に関する十分な情報がありません。

主要情報

Kandarp Amin

最高経営責任者

₹8.4m

報酬総額

CEO給与比率	100.0%
CEO在任期間	24.8yrs
CEOの所有権	34.1%
経営陣の平均在職期間	データなし
取締役会の平均在任期間	4.8yrs

経営陣の近況

Recent updates

CEO報酬分析

Archit Organosys の収益と比較して、Kandarp Amin の報酬はどのように変化したか？
日付	総報酬	給与	会社業績
Jun 30 2024	n/a	n/a	₹26m
Mar 31 2024	₹8m	₹8m	₹33m
Dec 31 2023	n/a	n/a	₹34m
Sep 30 2023	n/a	n/a	₹61m
Jun 30 2023	n/a	n/a	₹88m
Mar 31 2023	₹8m	₹8m	₹113m
Dec 31 2022	n/a	n/a	₹113m
Sep 30 2022	n/a	n/a	₹111m
Jun 30 2022	n/a	n/a	₹94m
Mar 31 2022	₹8m	₹8m	₹82m
Dec 31 2021	n/a	n/a	₹79m
Sep 30 2021	n/a	n/a	₹74m
Jun 30 2021	n/a	n/a	₹71m
Mar 31 2021	₹8m	₹8m	₹50m
Dec 31 2020	n/a	n/a	₹29m
Sep 30 2020	n/a	n/a	₹8m
Jun 30 2020	n/a	n/a	-₹8m
Mar 31 2020	₹8m	₹8m	-₹8m
Dec 31 2019	n/a	n/a	₹497k
Sep 30 2019	n/a	n/a	-₹19m
Jun 30 2019	n/a	n/a	-₹25m
Mar 31 2019	₹6m	₹6m	-₹47m
Dec 31 2018	n/a	n/a	-₹41m
Sep 30 2018	n/a	n/a	-₹10m
Jun 30 2018	n/a	n/a	₹11m
Mar 31 2018	₹5m	₹5m	₹5m

報酬と市場: Kandarpの総報酬 ($USD 99.47K ) は、 Indian市場 ($USD 42.63K ) の同規模の企業の平均を上回っています。

報酬と収益: Kandarpの報酬は、過去 1 年間の会社の業績と一致しています。

CEO（最高経営責任者

Kandarp Amin (67 yo)

24.8yrs

在職期間

₹8,400,000

報酬

Mr. Kandarp Krishnakant Amin serves as Chairman of Archit Organosys Limited and has been its Whole-Time Director since January 22, 2000. He joined Archit Organosys Limited since January 22, 2000. He has ex...

取締役

名称	ポジション	在職期間	報酬	所有権
Kandarp Amin	Chairman	24.8yrs	₹8.40m	34.15% ₹ 305.1m
Archana Amin	Whole-Time Director	25.2yrs	₹7.80m	22.19% ₹ 198.3m
Archit Amin	Whole Time Director	7.5yrs	₹6.60m	8.3% ₹ 74.2m
Nikul Patel	Independent Non-Executive Director	3.3yrs	₹20.00k	0.000010% ₹ 89.3
Shreeraj Desai	Independent Non-Executive Director	4.8yrs	₹15.00k	データなし
Vatsal Vora	Additional Independent Director	1.4yrs	₹5.00k	データなし
Bhavin Shah	Additional Independent Director	1.4yrs	₹5.00k	0.074% ₹ 659.7k

4.8yrs

平均在職期間

41yo

平均年齢

経験豊富なボード: 524640の取締役会は経験豊富であると考えられます ( 4.8年の平均在任期間)。

Archit Organosys マネジメント

マネジメント 基準チェック /24

主要情報

経営陣の近況

Archit Organosys Limited Appoints Pruthvik R. Soni as the Company Secretary & Compliance Officer

Archit Organosys Limited Announces Resignation of Purvi S. Mitna as Company Secretary

Archit Organosys Limited, Annual General Meeting, Sep 09, 2024

Archit Organosys Limited, Annual General Meeting, Sep 09, 2024

Archit Organosys Limited Appoints Purvi S. Mitna as the Company Secretary & Compliance Officer

Whole Time Director recently bought ₹796k worth of stock

Recent updates

Archit Organosys Limited Appoints Pruthvik R. Soni as the Company Secretary & Compliance Officer

Archit Organosys Limited Announces Resignation of Purvi S. Mitna as Company Secretary

Archit Organosys Limited, Annual General Meeting, Sep 09, 2024

Archit Organosys Limited, Annual General Meeting, Sep 09, 2024

Archit Organosys Limited to Report Q2, 2025 Results on Nov 14, 2024

First quarter 2025 earnings released: EPS: ₹0.49 (vs ₹0.77 in 1Q 2024)

Archit Organosys Limited to Report Q1, 2025 Results on Aug 08, 2024

Archit Organosys Limited Appoints Purvi S. Mitna as the Company Secretary & Compliance Officer

Whole Time Director recently bought ₹796k worth of stock

Investor sentiment improves as stock rises 25%

Full year 2024 earnings released: EPS: ₹1.60 (vs ₹5.53 in FY 2023)

New major risk - Market cap size

Archit Organosys Limited to Report Q4, 2024 Results on May 30, 2024

Investor sentiment improves as stock rises 18%

Kandarp Amin, Archana Amin, Archit Amin and Suchit Amin agreed to acquire 50.01% stake in Novel and Nano Xtreme Solutions LLP from Archit Organosys Limited (BSE:524640) for INR 0.5 million.

Kandarp Amin, Archana Amin, Archit Amin and Suchit Amin agreed to acquire 50.01% stake in Novel and Nano Xtreme Solutions LLP from Archit Organosys Limited (BSE:524640) for INR 0.5 million.

Now 20% undervalued after recent price drop

New major risk - Market cap size

Third quarter 2024 earnings released: ₹0.22 loss per share (vs ₹1.09 profit in 3Q 2023)

New minor risk - Profit margin trend

Archit Organosys Limited Declares Dividend

New minor risk - Earnings quality

Full year 2023 earnings released: EPS: ₹5.53 (vs ₹4.01 in FY 2022)

Archit Organosys Limited to Report Q3, 2024 Results on Feb 14, 2024

Upcoming dividend of ₹0.50 per share at 1.0% yield

Archit Organosys Limited Proposes Declare

Archit Organosys Limited to Report Q1, 2024 Results on Aug 14, 2023

Investor sentiment improves as stock rises 16%

Upcoming dividend of ₹0.50 per share at 0.9% yield

Archit Organosys Limited, Annual General Meeting, Aug 22, 2023

Full year 2023 earnings released: EPS: ₹5.53 (vs ₹4.01 in FY 2022)

Archit Organosys Limited Recommends a Final Dividend for the Financial Year Ended March 31, 2023

Chairman & Whole Time Director recently bought ₹507k worth of stock

Chairman & Whole Time Director recently bought ₹1.3m worth of stock

Investor sentiment deteriorated over the past week

Third quarter 2023 earnings released: EPS: ₹1.09 (vs ₹0.99 in 3Q 2022)

Archit Organosys Limited to Report Q3, 2023 Results on Jan 13, 2023

Investor sentiment improved over the past week

Second quarter 2023 earnings released: EPS: ₹1.49 (vs ₹0.68 in 2Q 2022)

Second quarter 2023 earnings released: EPS: ₹1.49 (vs ₹0.68 in 2Q 2022)

Archit Organosys Limited to Report Q2, 2023 Results on Nov 11, 2022

Archit Organosys Limited Announces Chief Financial Officer Changes

Investor sentiment improved over the past week

Archit Organosys Limited Approves Dividend

Investor sentiment improved over the past week

Archit Organosys Limited, Annual General Meeting, Sep 08, 2022

First quarter 2023 earnings released: EPS: ₹2.01 (vs ₹1.42 in 1Q 2022)

Archit Organosys Limited to Report Q1, 2023 Results on Jul 25, 2022

Archit Organosys Limited Recommends Final Dividend for the Financial Year Ended March 31, 2022

Investor sentiment improved over the past week

Archit Organosys Limited Announces Appointment of Vijay A. Boliya as Company Secretary and Compliance Officer, Effective March 1, 2022

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Archit Organosys Limited Announces Resignation of Anchal Bansal as Company Secretary and Compliance Officer

Second quarter 2022 earnings released: EPS ₹0.68 (vs ₹0.70 in 2Q 2021)

First quarter 2022 earnings released: EPS ₹1.42 (vs ₹0.55 in 1Q 2021)

Independent Director Rajendraprasad Shah has left the company

Investor sentiment improved over the past week

Full year 2021 earnings released: EPS ₹3.33 (vs ₹0.53 loss in FY 2020)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Third quarter 2021 earnings released: EPS ₹1.02 (vs ₹0.37 loss in 3Q 2020)

Archit Organosys Limited to Report Q3, 2021 Results on Feb 13, 2021

Investor sentiment improved over the past week

New 90-day high: ₹25.00

New 90-day high: ₹24.55

Investor sentiment deteriorated over the past week

New 90-day high: ₹23.80

Archit Organosys Limited to Report First Half, 2021 Results on Nov 09, 2020

マネジメント基準チェック /24